XML 69 R53.htm IDEA: XBRL DOCUMENT v3.5.0.1
Revenue Recognition (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2016
Mar. 31, 2015
Revenue Recognition [Line Items]        
Revenue, Net, Total $ 647,000 $ 2,000 $ 1,561,000 $ 15,000
License and Maintenance Revenue 21,000 $ 64,000 21,000 $ 64,000
KOREA, REPUBLIC OF | Korean Pharmaceutical Company [Member]        
Revenue Recognition [Line Items]        
Deferred Revenue 500,000   $ 500,000  
Deferred Revenue Recognition Period     10 years 10 years
CANADA | Canadian Based Supplier [Member]        
Revenue Recognition [Line Items]        
Deferred Revenue $ 250,000   $ 250,000  
Deferred Revenue Recognition Period     7 years 7 years